These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23589040)

  • 21. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.
    Mologni L; Marchesi E; Nielsen PE; Gambacorti-Passerini C
    Cancer Res; 2001 Jul; 61(14):5468-73. PubMed ID: 11454693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetics, gene fusions, and cancer.
    Glassman AB
    Ann Clin Lab Sci; 1995; 25(5):389-93. PubMed ID: 7486813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lentivirus‑mediated RIG‑I knockdown relieves cell proliferation inhibition, cell cycle arrest and apoptosis in ATRA‑induced NB4 cells via the AKT‑FOXO3A signaling pathway in vitro.
    Chen L; Cui YB; Si YL; Su WD; Wang XC; Pang H; Qiu LJ
    Mol Med Rep; 2017 Sep; 16(3):2556-2562. PubMed ID: 28656276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
    Wang W; DU Y; Lin GQ; Li NN; Sun BZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis.
    Puccetti E; Beissert T; Güller S; Li JE; Hoelzer D; Ottmann OG; Ruthardt M
    Oncogene; 2003 Oct; 22(44):6900-8. PubMed ID: 14534537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research progress in cytoplasmic PML gene functions].
    Xu XH; Sun YY; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):857-60. PubMed ID: 24989309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure and functions of isoforms of polyfunctional tumoral suppressor PML].
    Zinov'eva MV; Vaĭshlia NA; Vinogradova TV; Kopantsev EP; Sverdlov ED
    Mol Gen Mikrobiol Virusol; 2009; (2):15-21. PubMed ID: 19517805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.
    Occhionorelli M; Santoro F; Pallavicini I; Gruszka A; Moretti S; Bossi D; Viale A; Shing D; Ronzoni S; Muradore I; Soncini M; Pruneri G; Rafaniello P; Viale G; Pelicci PG; Minucci S
    Leukemia; 2011 May; 25(5):814-20. PubMed ID: 21331069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of red orpiment on cell morphology and expression of PML mRNA and protein in NB4 and HL-60 cells.
    Zhong L; Chen F; Han J; Shao N; Ouyang R
    Chin Med J (Engl); 2003 Jan; 116(1):148-50. PubMed ID: 12667410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on the treatment of the p15 gene combined with Bcr-abl-specific siRNA and STI571 for chronic myeloid leukemia.
    Wang W; Du Y; Li NN; Lv FF; Lin GQ
    Genet Mol Res; 2014 May; 13(2):4089-101. PubMed ID: 24938701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
    Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
    Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
    Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
    Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
    Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
    Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of siRNA targeting PML-RARa fusion gene on activity of the acute promyelocytic leukemia cell line NB4].
    Luo H; Pan Y; Hao X; Cao X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Aug; 31(4):850-4. PubMed ID: 25464801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control.
    Topcu Z; Mack DL; Hromas RA; Borden KL
    Oncogene; 1999 Nov; 18(50):7091-100. PubMed ID: 10597310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PML(NLS(-)) inhibits cell apoptosis and promotes proliferation in HL-60 cells.
    Gao YM; Zhong L; Zhang X; Hu XX; Liu BZ
    Int J Med Sci; 2013; 10(5):498-507. PubMed ID: 23532460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The influence of different WT1 gene isoforms expression pattern on the differentiation of leukemia cell line NB4].
    Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):543-7. PubMed ID: 16468332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.